### Analysis of rs794727152 and Its Influence on Clinical Phenotype

The variant **rs794727152** is located in the **SCN2A** gene, which encodes the sodium channel protein type 2 subunit alpha. Variants in this gene are known to influence neuronal excitability and are associated with a spectrum of neurodevelopmental and epileptic disorders. Below is a detailed analysis of how this variant influences clinical phenotypes:

---

### 1. **Variant Identification**
- **rs Number**: [rs794727152](https://identifiers.org/dbsnp/rs794727152)
- **Gene**: SCN2A
- **Chromosomal Location**: Chromosome 2, position 165342465 (GRCh38)
- **HGVS Notations**:
  - **cDNA**: NM_021007.3:c.2558G>A (p.Arg853Gln) and NM_021007.3:c.2558G>C (p.Arg853Pro)
  - **Protein**: p.Arg853Gln (R853Q) and p.Arg853Pro (R853P)
  - **Genomic**: chr2:g.165342465G>A and chr2:g.165342465G>C

---

### 2. **Disease Associations**
The variant rs794727152 has been associated with several clinical phenotypes, primarily **developmental and epileptic encephalopathies (DEE)**. Below are the specific conditions linked to this variant:

#### a. **Pathogenicity Evidence**
- **Pathogenic (P)** and **Likely Pathogenic (LP)** classifications in ClinVar.
- Associated conditions:
  - **Developmental and epileptic encephalopathy, 11 (DEE11)** ([MedGen: C3150987](https://www.ncbi.nlm.nih.gov/medgen/C3150987))
  - **Complex neurodevelopmental disorder** ([MedGen: C5568766](https://www.ncbi.nlm.nih.gov/medgen/C5568766))
  - **West syndrome** ([MedGen: C0037769](https://www.ncbi.nlm.nih.gov/medgen/C0037769))
  - **Benign familial infantile seizures, 3 (BFIS3)** ([MedGen: C1843140](https://www.ncbi.nlm.nih.gov/medgen/C1843140))

#### b. **Functional Impact**
- **R853Q** and **R853P** substitutions occur in a highly conserved region of the SCN2A protein, which is critical for sodium channel function.
- These substitutions likely alter channel gating or ion conductance, leading to neuronal hyperexcitability or hypoexcitability, depending on the specific mutation.

#### c. **Predictive Models**
- **SIFT**: 0.0 (deleterious)
- **PolyPhen-2**: 0.999 (probably damaging)
- **AlphaMissense**: 0.9953–0.9989 (high pathogenicity likelihood)

---

### 3. **Literature Evidence**
- Variants at this position have been reported in studies of **early-onset epileptic encephalopathies** and **autism spectrum disorders**. These studies highlight the role of SCN2A mutations in disrupting neuronal signaling pathways.
- Specific references are not provided in the TogoVar dataset, but similar variants in SCN2A are well-documented in epilepsy research.

---

### 4. **Allele Frequency Comparison**
- No allele frequency data is available for rs794727152 in the TogoVar dataset. This suggests that the variant is likely rare or absent in population databases, consistent with its association with severe, rare diseases.

---

### 5. **GWAS Findings**
- No genome-wide association studies (GWAS) findings are directly linked to rs794727152. However, SCN2A is a known candidate gene in GWAS for epilepsy and neurodevelopmental disorders.

---

### 6. **TogoVar Link**
- [TogoVar page for rs794727152](https://togovar.org/variant/tgv417503265)

---

### Clinical Implications
The location of rs794727152 in the SCN2A gene is critical for its clinical impact. Variants at this position (R853Q and R853P) disrupt the function of the sodium channel, leading to a spectrum of phenotypes ranging from **severe epileptic encephalopathies** to **milder neurodevelopmental disorders**. The specific phenotype may depend on the exact amino acid substitution and its effect on channel function.

---

### 日本語での説明

#### 1. **変異の特定**
- **rs番号**: [rs794727152](https://identifiers.org/dbsnp/rs794727152)
- **遺伝子**: SCN2A
- **染色体位置**: 染色体2、165342465番目 (GRCh38)
- **HGVS表記**:
  - **cDNA**: NM_021007.3:c.2558G>A (p.Arg853Gln) および NM_021007.3:c.2558G>C (p.Arg853Pro)
  - **タンパク質**: p.Arg853Gln (R853Q) および p.Arg853Pro (R853P)
  - **ゲノム**: chr2:g.165342465G>A および chr2:g.165342465G>C

#### 2. **疾患との関連**
この変異は主に**発達性およびてんかん性脳症 (DEE)** に関連しています。
- 関連疾患:
  - **発達性およびてんかん性脳症11型 (DEE11)**
  - **複雑な神経発達障害**
  - **ウエスト症候群**
  - **良性家族性乳児てんかん3型 (BFIS3)**

#### 3. **予測モデル**
- **SIFT**: 0.0（有害）
- **PolyPhen-2**: 0.999（おそらく有害）
- **AlphaMissense**: 0.9953–0.9989（高い病原性の可能性）

#### 4. **臨床的影響**
この変異はSCN2Aタンパク質の重要な部位に位置し、ナトリウムチャネルの機能を変化させることで、神経の過剰興奮または低興奮を引き起こします。その結果、てんかんや神経発達障害が発症します。

#### 5. **TogoVarリンク**
- [TogoVarページ](https://togovar.org/variant/tgv417503265)

---

If you have further questions or need additional details, feel free to ask!